Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Ataxia / Spastic Paraplegia Panel Centogene AG - the Rare Disease Company Germany | 442 | 443 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 638 | 419 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 480 | 254 |
|
PreventionGenetics, part of Exact Sciences United States | 15 | 14 |
|
Invitae Hereditary Spastic Paraplegia Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 98 | 62 |
|
GJC2 Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 3 | 1 |
|
GJC2 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 3 | 1 |
|
Baylor Genetics United States | 3 | 1 |
|
Hereditary Lymphedema via the GJC2 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Lymphedema, hereditary, IC (sequence analysis of GJC2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Vascular Anomalies and Mosaic Disorders Children's Hospital of Los Angeles, Center for Personalized Medicine United States | 8 | 4 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
Lymphatic malformations and related disorders panel. NGS panel of 11 genes. Genologica Medica Spain | 31 | 11 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.